Riboswitches: From living biosensors to novel targets of antibiotics

Gene. 2016 Nov 5;592(2):244-59. doi: 10.1016/j.gene.2016.07.035. Epub 2016 Jul 16.

Abstract

Riboswitches are generally located in 5'-UTR region of mRNAs and specifically bind small ligands. Following ligand binding, gene expression is controlled mostly by transcription termination, translation inhibition or mRNA degradation processes. More than 30 classes of known riboswitches have been identified by now. Most riboswitches consist of an aptamer domain and an expression platform. The aptamer domain of each class of riboswitch is a conserved structure and stabilizes specific structures of the expression platforms through binding to specific compounds. In this review, we are highlighting most aspects of riboswitch research including the novel riboswitch discoveries, routine methods for discovering and investigating riboswitches along with newly discovered classes and mechanistic principles of riboswitch-mediated gene expression control. Moreover, we will give an overview about the potential of riboswitches as therapeutic targets for antibiotic design and also their utilization as biosensors for molecular detection.

Keywords: Antibacterials; Biosensor; Drug design; Engineered riboswitches; RNA; Riboswitch.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Biosensing Techniques / methods*
  • Drug Discovery / methods*
  • Humans
  • Riboswitch / drug effects*
  • Riboswitch / genetics

Substances

  • Anti-Bacterial Agents
  • Riboswitch